Press Releases

BOC Sciences Optimizes PROTAC Platform to Boost Related Research

BOC Sciences optimizes its PROTAC platform of protein degradation technology to boost PROTAC research and development.

Creative Bioarray Develops Cell Immortalization Kits and Immortalized Human Cells to Support Immortalized Cell Research

Acroscell Releases Voltage-gated Potassium Channels to Accelerate The Development of Drug Development

Creative Bioarray Supplies Comprehensive Cell Culture Media to Meet Diverse Requirements for Cell Culture Applications

VERICHEM INTRODUCES LIQUID STABLE REFERENCE MATERIALS FOR AMMONIA TESTING WITH EXTENDED STABILITIES

VERICHEM releases multi-level set of liquid stable and ready-to-use clinical reference materials for the calibration and calibration verification of Ammonia assays with extended shelf-life stability claims.

Creative Biogene Launches A Large Panel of Genome Editing Services to Accelerate Bioprocess of Drug Development

Qvirus Platform Offers Custom Baculovirus Production to Accelerate High-level Gene Expression

Microbiosci Provides High Quality Bacillus Fermentation Services in Different Scales to Accelerate The Development of Microbial Technologies

Creative Biogene Unveils Comprehensive Services of Bacterial Genome Editing

Creative Biogene unveils its comprehensive services of bacterial genome editing for worldwide pharmaceutical partners after the self-optimization of homologous recombination technology and the CRISPR/Cas9 platform.

Absolute Antibody Licenses Novel Fc Silencing Technology from mAbsolve

CD Formulation Announces to Offer Nitrosamine Impurities Analysis Service for Drug Formulation Projects

Earlier this month, CD Formulation announces that it is now capable of providing nitrosamine impurities analysis service for customers who are involved with drug formulation projects and need help from CRO companies like CD Formulation.

CPHI North America opens as 65% of US companies forecast growth in excess of 20% in 2022

BioIVT Acquires Commercial Blood Bank Tennessee Blood Services

This transaction expands BioIVT’s donor network and increases its capacity to provide fresh whole blood, plasma, serum, and red blood cells for drug and diagnostic development.

Creative Biogene Released One-Stop C. elegans Aging Research Services to Fuel Your Aging Studies

Creative Biogene announced the release of one-stop C. elegans aging research services to accelerate the speed of partners’ aging studies.

Society of Toxicology Announced ScitoVation’s Senior Research Fellow, Jeffrey W. Fisher, PhD, Awarded 2022 SOT Arnold J. Lehman

ScitoVation has announced that Jeffrey W. Fisher, PhD has been awarded the 2022 Society of Toxicology (SOT) Arnold J. Lehman Award.

MicrobioSeq Releases PCR-based Microbial Antibiotic Resistance Gene Analysis Service

MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics MicrobioSeq is committed to delivering comprehensive microbial solutions to human health, agriculture, the environment, and industry by characterizing microbiomes and leveraging microorganisms. The company has recently announced the launch of PCR-based microbial antibiotic resistance gene analysis service to help researchers develop new antimicrobial medicines to address the worldwide threat of antibiotic resistance.

CD Genomics: Bioinformatics-Analysis Division Provides Genotyping Analysis Service for Studying Genetic Variations

The Bioinformatics-analysis division is a new division of CD Genomics that provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis services. CD Genomics recently launched various types of genotyping analysis services, including analysis of data generated by different classification techniques, such as whole-genome sequencing, whole-exome sequencing, whole-genome SNP chips, and mass spectrometry.

CD ComputaBio Launches Homology Modeling Service for Drug Screening and Discovery

As a reliable computational biology service provider based in New York, CD ComputaBio has recently launched homology modeling service to help researchers deeply understand the structure-activity relationship of the target protein, and provide strong support for structure-based rational drug design, protein function research, and protein engineering research. Relying on its professional team and advanced technology, as well as high-quality products and services, CD ComputaBio has gained a solid reputation.

CD ComputaBio Releases Molecular Docking Service for Enzymology Research and Drug Design

CD ComputaBio, a reliable computational biology service provider located in New York, always hammers at researches and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. Recently, the product manager announced the launch of molecular docking service, which has a wide range of applications in the field of enzymology research and drug design.

ChromaCode’s Emergency Use Authorization (EUA) Expanded by FDA for High-Throughput HDPCR™ SARS-CoV-2 Real-Time PCR Assay

Molecular diagnostics company ChromaCode receives expanded EUA authorization for its high throughput HDPCR SARS-Co-V-2 real time PCR assay to include several new qPCR instruments and use of 384-well plates.